Answers are grounded in this paper and cite their sources.
The purpose of this preliminary study was to investigate changes in plasma concentrations of zinc-α2-glycoprotein (ZAG), a lipid mobilizing hormone, in obese subjects following Roux-En-Y Gastric Bypass (RYGB) surgery or a very low calorie diet (VLCD).Fasting blood concentrations and anthropometric measurements were measured pre and 12 weeks post intervention.14 healthy, obese individuals underwent either RYGB (N=6) surgery or a VLCD (N=8).Body composition and fasting plasma ZAG concentrations were measured at baseline (pre) and 12 weeks post intervention (post).At pre-intervention baseline, there was no difference in plasma ZAG between the two intervention groups.Post-intervention, there was a significant overall reduction (F(1,11) = 32.8,p<0.001) in plasma ZAG, which was significant only within the RYGB group from pre to post intervention (33.2 ± 5.7 µg/ml to 26.7 ± 4.8 µg/ml (p<0.015)) and significantly greater than the change within the VLCD group.The change in ZAG was inversely correlated across groups with BMI reduction (r= -0.60, p<0.05), % body fat reduction (r= -0.68, p<0.015), reduction in weight (r= -0.58, p<0.05), and % weight loss (r= -0.70, p<0.05).Overall, subjects who underwent RYGB or VLCD had a significant reduction in plasma ZAG.This reduction was significant within the RYGB group alone, who lost a larger amount of weight than the VLCD group, which suggests that ZAG may have a protective effect during marked weight loss.lipid mobilization and utilization in the obese [15].ZAG is inversely correlated with body mass index (BMI), body weight, body fat percentage, and fat mass [16,17].Genetically obese ob/ob mice that were given ZAG intravenously or intraperitoneally, lost weight [10,18] and body fat [11].In this study, we examined plasma ZAG concentrations pre and post two weight loss interventions, RYGB or a very low calorie diet (VLCD), and we hypothesized that ZAG would increase with weight loss. Materials and methods DesignDuring the period from December 30 th , 2010 through October 9 th , 2012, 14 severely obese subjects (BMI = 43.34± 3.32 kg/m 2 ) were recruited from individuals seeking weight loss treatment at St. Luke's-Roosevelt Hospital, New York, NY from a larger study.Candidates for RYGB at the Center for Bariatric Surgery and Metabolic Disease were enrolled in the surgical group (N=6, male/female: 0/6), and candidates,
No takes yet. Share an insight, caveat, or question.
Morse et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: